Clinical Trial Update: A Study of ARRY-334543 and Gemcitabine in Patients With Advanced Cancer and Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 study evaluating ARRY-334543 with gemcitabine in patients with advanced cancer, including pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• ARRY-334543
• Gemzar (gemcitabine)

Snippet

Sponsor: Array BioPharma | Conditions: Advanced Cancer, Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED